Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 8713263, 16 pages
https://doi.org/10.1155/2018/8713263
Research Article

Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability

1Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun 130033, China
2Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun 130033, China
3Cardiology Department, China-Japan Union Hospital of Jilin University, Changchun 130033, China
4Department of Gastrointestinal Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang 110032, China
5Teaching Office, College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China
6Pediatrics, Liuhe District Hospital of Nanjing, Nanjing 211500, China
7Shihezi University, Shihezi 832003, China
8Blood Transfusion Department, China-Japan Union Hospital of Jilin University, Changchun 130033, China
9Breast Surgery Department, China-Japan Union Hospital of Jilin University, Changchun 130033, China

Correspondence should be addressed to Tianhua Yu; moc.621@mm_htuy and Changlong Song; moc.621@a51lgnahcgnoS

Received 1 October 2017; Accepted 4 December 2017; Published 7 February 2018

Academic Editor: Majeti N. V. R. Kumar

Copyright © 2018 Lirong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Kager, U. Potschger, and S. Bielack, “Review of mifamurtide in the treatment of patients with osteosarcoma,” Therapeutics and Clinical Risk Management, vol. 6, pp. 279–286, 2010. View at Publisher · View at Google Scholar
  2. L. H. Chung, P. K. Wu, C. F. Chen, H. K. Weng, T. H. Chen, and W. M. Chen, “Pathological fractures in predicting clinical outcomes for patients with osteosarcoma,” BMC Musculoskeletal Disorders, vol. 17, no. 1, p. 503, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Beuth, B. Schneider, R. VAN Leendert, and G. Uhlenbruck, “Large-scale survey of the impact of complementary medicine on side-effects of adjuvant hormone therapy in patients with breast cancer,” In Vivo, vol. 30, no. 1, pp. 73–75, 2016. View at Google Scholar
  4. J. Beuth, R. Van Leendert, K. Pempelfort, B. Schneider, C. Grund, and U. Engelmann, “Complementary medicine down-regulates side-effects of hormone therapy in prostate cancer patients,” In Vivo, vol. 5, pp. 979–982, 2014. View at Google Scholar
  5. S. Johal, C. Knight, M. J. Bell, and S. Ralston, “PCN26 long-term fiscal implications of mepact in the treatment of high-grade non-metastatic osteosarcoma: a budget impact model and a lifetime tax perspective,” Value in Health, vol. 14, no. 7, article A438, 2011. View at Publisher · View at Google Scholar
  6. K. Venkatakrishnan, Y. Liu, D. Noe et al., “Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment,” British Journal of Clinical Pharmacology, vol. 77, no. 6, pp. 998–1010, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Anderson, M. Tomaras, and K. McConnell, “Mifamurtide in osteosarcoma - a practical review,” Drugs of Today, vol. 46, no. 5, pp. 327–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Das, R. Miller, P. Lee et al., “A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway,” Tumour Biology, vol. 36, no. 9, pp. 7027–7034, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. K. Song and J. M. Bae, “Citrus fruit intake and breast cancer risk: a quantitative systematic review,” Journal of Breast Cancer, vol. 16, no. 1, pp. 72–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Gonzalez, N. Sala, and T. Rokkas, “Gastric cancer: epidemiologic aspects,” Helicobacter, vol. 18, Supplement 1, pp. 34–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. I. Park, H. S. Park, A. Nagappan et al., “Induction of the cell cycle arrest and apoptosis by flavonoids isolated from Korean Citrus aurantium L. in non-small-cell lung cancer cells,” Food Chemistry, vol. 135, no. 4, pp. 2728–2735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Lee, K. I. Park, H. S. Park et al., “Flavonoids isolated from Korea Citrus aurantium L. induce G2/M phase arrest and apoptosis in human gastric cancer AGS cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 515901, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Zhao, D. Fan, B. Ru et al., “6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells,” European Journal of Cancer, vol. 68, pp. 38–50, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Lim, S. Park, F. W. Bazer, and G. Song, “Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the PI3K/AKT and MAPK signaling pathways,” Journal of Cellular Biochemistry, vol. 118, no. 5, pp. 1118–1131, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. B. B. Chandrika, M. Steephan, T. R. S. Kumar, A. Sabu, and M. Haridas, “Hesperetin and naringenin sensitize HER2 positive cancer cells to death by serving as HER2 tyrosine kinase inhibitors,” Life Sciences, vol. 160, pp. 47–56, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Franke, R. V. Cooney, S. M. Henning, and L. J. Custer, “Bioavailability and antioxidant effects of orange juice components in humans,” Journal of Agricultural and Food Chemistry, vol. 53, no. 13, pp. 5170–5178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Li, M. L. Yan, and Q. Yu, “Identification of candidate drugs for the treatment of metastatic osteosarcoma through a subpathway analysis method,” Oncology Letters, vol. 13, no. 6, pp. 4378–4384, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. S. W. Lim, D. R. Lee, B. K. Choi et al., “Protective effects of a polymethoxy flavonoids-rich Citrus aurantium peel extract on liver fibrosis induced by bile duct ligation in mice,” Asian Pacific Journal of Tropical Medicine, vol. 9, no. 12, pp. 1158–1164, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. S. H. Lee, S. Yumnam, G. E. Hong et al., “Flavonoids of Korean Citrus aurantium L. induce apoptosis via intrinsic pathway in human hepatoblastoma HepG2 cells,” Phytotherapy Research, vol. 29, no. 12, pp. 1940–1949, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Chen, Y. Cao, B. Bao, L. Zhang, and A. Ding, “Antioxidant capacity of Typha angustifolia extracts and two active flavonoids,” Pharmaceutical Biology, vol. 55, no. 1, pp. 1283–1288, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ben Hmidene, M. Hanaki, K. Murakami, K. Irie, H. Isoda, and H. Shigemori, “Inhibitory activities of antioxidant flavonoids from Tamarix gallica on amyloid aggregation related to Alzheimer’s and type 2 diabetes diseases,” Biological and Pharmaceutical Bulletin, vol. 40, no. 2, pp. 238–241, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Benavente-Garcia and J. Castillo, “Update on uses and properties of Citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity,” Journal of Agricultural and Food Chemistry, vol. 56, no. 15, pp. 6185–6205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Umeno, V. Biju, and Y. Yoshida, “In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer’s disease, Parkinson’s disease, and diabetes,” Free Radical Research, vol. 51, no. 4, pp. 413–427, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. Thomson, A. R. Giuliano, J. W. Shaw et al., “Diet and biomarkers of oxidative damage in women previously treated for breast cancer,” Nutrition and Cancer, vol. 51, no. 2, pp. 146–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Wang, W. Wang, and E. Qiu, “Protection of oxidative stress induced apoptosis in osteosarcoma cells by dihydromyricetin through down-regulation of caspase activation and up-regulation of BcL-2,” Saudi Journal of Biological Sciences, vol. 24, no. 4, pp. 837–842, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. C. R. Rossi, A. Vecchiato, M. Foletto et al., “Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas,” Cancer, vol. 73, no. 8, pp. 2140–2146, 1994. View at Publisher · View at Google Scholar
  27. S. T. Huang, C. C. Huang, J. M. Sheen et al., “Phyllanthus urinaria’s inhibition of human osteosarcoma xenografts growth in mice is associated with modulation of mitochondrial fission/fusion machinery,” The American Journal of Chinese Medicine, vol. 44, no. 7, pp. 1507–1523, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. P.-U. Tunn and P. Reichardt, “Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients,” Oncology Research and Treatment, vol. 30, no. 5, pp. 228–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. Franke, L. J. Custer, L. R. Wilkens et al., “Liquid chromatographic–photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood,” Journal of Chromatography B, vol. 777, no. 1-2, pp. 45–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. F. I. Kanaze, E. Kokkalou, M. Georgarakis, and I. Niopas, “Validated high-performance liquid chromatographic method utilizing solid-phase extraction for the simultaneous determination of naringenin and hesperetin in human plasma,” Journal of Chromatography B, vol. 801, no. 2, pp. 363–367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. T. G. Araújo, A. G. Oliveira, J. F. Vecina et al., “Treatment with Parkinsonia aculeata combats insulin resistance-induced oxidative stress through the increase in PPARγ/CuZn-SOD axis expression in diet-induced obesity mice,” Molecular and Cellular Biochemistry, vol. 419, no. 1-2, pp. 93–101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Wan, L. Deng, C. Zhang et al., “Chikusetsu saponin V attenuates H2O2-induced oxidative stress in human neuroblastoma SH-SY5Y cells through Sirt1/PGC-1α/Mn-SOD signaling pathways,” Canadian Journal of Physiology and Pharmacology, vol. 94, no. 9, pp. 919–928, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Fujii, Y. Yonekura, Y. Yamashita et al., “Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction,” British Journal of Pharmacology, vol. 173, no. 8, pp. 1302–1313, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Jansen, P. Beekhof, D. Viezeliene, V. Muzakova, and J. Skalicky, “Long-term stability of cancer biomarkers in human serum: biomarkers of oxidative stress and redox status, homocysteine, CRP and the enzymes ALT and GGT,” Biomarkers in Medicine, vol. 9, no. 5, pp. 425–432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Dong, D. Li, H. Liu, and Y. Zhao, “SOD3 and eNOS genotypes are associated with SOD activity and NO,” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 328–334, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. He, X. Liang, C. Meng et al., “Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk,” International Orthopaedics, vol. 38, no. 8, pp. 1671–1676, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Qi, C. Zhao, H. Li et al., “Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma,” Tumor Biology, vol. 37, no. 7, pp. 9807–9811, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Campise, F. Bamonti, C. Novembrino et al., “Oxidative stress in kidney transplant patients,” Transplantation, vol. 76, no. 10, pp. 1474–1478, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. H. W. Eom, S. Y. Park, Y. H. Kim et al., “Bambusae Caulis in Taeniam modulates neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via HO-1- and Nrf-2-mediated pathways,” International Journal of Molecular Medicine, vol. 30, no. 6, pp. 1512–1520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Arul and P. Subramanian, “Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells,” Pathology & Oncology Research, vol. 19, no. 4, pp. 763–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Roohbakhsh, H. Parhiz, F. Soltani, R. Rezaee, and M. Iranshahi, “Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—a mini-review,” Life sciences, vol. 113, no. 1-2, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Aranganathan and N. Nalini, “Antiproliferative efficacy of hesperetin (citrus flavanoid) in 1, 2-dimethylhydrazine-induced colon cancer,” Phytotherapy Research, vol. 27, no. 7, pp. 999–1005, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Albanes, O. P. Heinonen, P. R. Taylor et al., “α-Tocopherol and β-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance,” Journal of the National Cancer Institute, vol. 88, no. 21, pp. 1560–1570, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Nelson, O. A. Panagiotou, G. M. Anic et al., “Metabolomics analysis of serum 25-hydroxy-vitamin D in the alpha-tocopherol, beta-carotene cancer prevention (ATBC) study,” International Journal of Epidemiology, vol. 45, no. 5, pp. 1458–1468, 2016. View at Publisher · View at Google Scholar
  45. A. M. Mondul, S. C. Moore, S. J. Weinstein, E. D. Karoly, J. N. Sampson, and D. Albanes, “Metabolomic analysis of prostate cancer risk in a prospective cohort: the alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study,” International Journal of Cancer, vol. 137, no. 9, pp. 2124–2132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Virtamo, P. R. Taylor, J. Kontto et al., “Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the alpha-tocopherol, beta-carotene cancer prevention study,” International Journal of Cancer, vol. 135, no. 1, pp. 178–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S. L. Hsiu, T. Y. Huang, Y. C. Hou, D. H. Chin, and P. D. L. Chao, “Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits,” Life Sciences, vol. 70, no. 13, pp. 1481–1489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Demonty, Y. Lin, Y. E. M. P. Zebregs et al., “The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women,” The Journal of Nutrition, vol. 140, no. 9, pp. 1615–1620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Z. Hua, J. Ying, J. Zhang et al., “Naringenin pre-treatment inhibits neuroapoptosis and ameliorates cognitive impairment in rats exposed to isoflurane anesthesia by regulating the PI3/Akt/PTEN signalling pathway and suppressing NF-κB-mediated inflammation,” International Journal of Molecular Medicine, vol. 38, no. 4, pp. 1271–1280, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. K. W. Cheng, X. Zeng, Y. S. Tang et al., “Inhibitory mechanism of naringenin against carcinogenic acrylamide formation and nonenzymatic browning in Maillard model reactions,” Chemical Research in Toxicology, vol. 22, no. 8, pp. 1483–1489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Moretti, L. Mazzi, G. Terzuoli et al., “Effect of quercetin, rutin, naringenin and epicatechin on lipid peroxidation induced in human sperm,” Reproductive Toxicology, vol. 34, no. 4, pp. 651–657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Orrego-Lagarón, M. Martínez-Huélamo, A. Vallverdú-Queralt, R. M. Lamuela-Raventos, and E. Escribano-Ferrer, “High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism,” British Journal of Nutrition, vol. 114, no. 2, pp. 169–180, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Assini, E. E. Mulvihill, A. C. Burke et al., “Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21,” Endocrinology, vol. 156, no. 6, pp. 2087–2102, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Nobre and V. Guirado, “Quality of life in adult intradural primary spinal cord tumors: short form–36 correlates with the scales of McCormick and Aminoff-Logue,” Value in Health, vol. 18, article A474, no. 7, 2015. View at Publisher · View at Google Scholar